Inventor · disambiguated record
Xingdong Zhao
Also filed as: ZHAO XINGDONG
19 granted patents·11 pending applications·17 citations·filing 2013–2022
89Inventor score
Files withSHANGHAI FOCHON PHARMACEUTICAL CO LTD13FOCHON PHARMACEUTICALS LTD8FOCHON BIOSCIENCES LTD7CHONGQING FOCHON PHARMACEUTICAL CO LTD1WANG WEIBO1
Top patents by PatentIndex Score
30 records- 0187US11053239B2Compounds as BLC-2-selective apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Jul 6, 2021·6 cites·13 claims
- 0278US11091478B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Aug 17, 2021·2 cites·32 claims
- 0377US9714235B2Quinazoline derivatives, compositions thereof, and use as pharmaceuticalsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 25, 2017·3 cites·2 claims
- 0473US10087195B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 2, 2018·2 cites·14 claims
- 0573US9206166B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 8, 2015·2 cites·20 claims
- 0671US9556171B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jan 31, 2017·2 cites·15 claims
- 0760US12312349B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2021·Granted May 27, 2025·0 cites·16 claims
- 0852US2025122191A1Compounds as bcl-2 inhibitorsFOCHON BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 0951US2023159527A1Compounds as bcl-2 inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1049US2023406856A1SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORSFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1149US2022354860A1Heterocyclic derivatives and use thereofFOCHON PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1248US2023174556A1Compounds as protein kinase inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1347US10053449B2Quinazoline derivatives, compositions thereof, and use as pharmaceuticalsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 21, 2018·0 cites·3 claims
- 1447US2023135215A1Compounds as cdk2/4/6 inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1546US10835535B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 17, 2020·0 cites·17 claims
- 1646US2023145305A1Compounds useful as kinase inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1745US10022374B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 17, 2018·0 cites·13 claims
- 1845US2022235049A1SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3,4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORSFOCHON PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1942US11485707B2Deuterated compounds as rock inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2019·Granted Nov 1, 2022·0 cites·20 claims
- 2042US9567342B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 14, 2017·0 cites·20 claims
- 2140US2022041588A1Substituted imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine compounds as ret kinase inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2240US2015284385A1Certain dipeptidyl peptidase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 2339US11168078B2Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenaseSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
- 2437US10800785B2Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 13, 2020·0 cites·18 claims
- 2536US11555042B2Macrocyclic compounds as TRK kinases inhibitorsFOCHON BIOSCIENCES LTD·Filed 2019·Granted Jan 17, 2023·0 cites·31 claims
- 2636US11459332B2Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitorsFOCHON BIOSCIENCES LTD·Filed 2019·Granted Oct 4, 2022·0 cites·22 claims
- 2736US10894038B2Indolizine derivatives, composition and methods of useSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·20 claims
- 2834US10450316B2Certain protein kinase inhibitorCHONGQING FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·0 cites·16 claims
- 2933US10328060B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 25, 2019·0 cites·15 claims
- 3033US2016145244A1Certain protein kinase inhibitorsWANG WEIBO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xingdong Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →